In 2023, the United States maintained its leadership with 28.98% of the top-cited publications in pulmonary and respiratory medicine, albeit with modest growth of 0.96% from the previous year. China marked significant progress with a 13.9% increase, further cementing its position as a key player. While the United Kingdom and Italy experienced moderate growth at 2.8% and 9.21% respectively, Germany saw a decline by -3.34%. Smaller countries like Peru (54.32%) and Ukraine (106.2%) showed remarkable growth, indicating burgeoning research activities. Portugal's contributions also rose by 13.9%, reflecting enhanced research capabilities.
Future trends to watch include China's continued rise, driven by increased investment in research and development. Additionally, emerging markets like Peru and Ukraine could contribute significantly as they continue their upward trajectory. The technological advancements and collaborations in respiratory medicine research may influence these trends, potentially altering the share distributions among countries in the coming years.
Top countries in Total Number of 10% Top-Cited Scientific Publications in Pulmonary and Respiratory Medicine Share by Country (Units (Publications))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 28.98 | 2023 | +1.92% | +0.96% | View data |
| 2 | 2 China | 11.36 | 2023 | +10.59% | +13.9% | View data |
| 3 | 3 United Kingdom | 9.88 | 2023 | +0.66% | +2.8% | View data |
| 4 | 4 Italy | 7.49 | 2023 | +9.59% | +9.21% | View data |
| 5 | 5 Canada | 4.35 | 2023 | +1.03% | +0.93% | View data |
| 6 | 6 Germany | 4.07 | 2023 | +0.16% | -3.34% | View data |
| 7 | 7 Australia | 4.01 | 2023 | +0.73% | +5.06% | View data |
| 8 | 8 France | 3.83 | 2023 | +1.29% | +0.58% | View data |
| 9 | 9 Japan | 3.66 | 2023 | +5.43% | +0.07% | View data |
| 10 | 10 Netherlands | 3.38 | 2023 | +2.61% | +0.078% | View data |
